INNOTEST® hPLAP

INNOTEST hPLAP (CE marked) is an enzyme immunoassay based on a unique monoclonal antibody for the quantitative determination of human placental alkaline phosphatase (hPLAP) in serum and heparinized plasma.

hPLAP (human placental alkaline phosphatase) is a marker for diagnosis and monitoring of seminomas.

    Contact sales for information
    CE marked
    INNOTEST® hPLAP

    Product number 80326

    96 Tests
    Please contact your local Fujirebio representative for the availability of this product in your country.

    Click here to navigate

    • Contact sales for information
    • Details
    • Conditions of sale
    • Citations
    • Documentation
    • Product inquiry

    • Details

      Features & Benefits

      • Sample material: Serum or heparinized plasma
      • Sample volume: 2 x 100µl 
      • Standards: Ready-to-use 
      • No sample dilution
      • Contents: 12 strips with 8 wells each 

       
      Background

      hPLAP is present in the serum of pregnant women, from the second trimester onwards, produced by the placental trophoblast.

      The discovery of hPLAP by the group of W.H. Fischman in serum and tumor tissue of a male cancer patient, extensive research has indicated that in a number of types of cancer hPLAP is present in the patient's serum.

      The application of monoclonal antibodies specific for hPLAP enables measurement of this enzyme without interference from other alkaline phosphatase (AP, EC 3.1.3.1) isoenzymes.

      The hPLAP assay is an additional tool in the confirmation of diagnosis and in the monitoring of cancer patients, particularly those with seminoma, testicular, or ovarian cancer. Persistently increasing hPLAP levels can be associated with progressive malignant disease or poor response to therapy, whereas declining hPLAP levels may indicate response to treatment or of recovery.

      See:

      • Human Placental Alkaline Phosphatase (hPLAP) is the Most Frequently Elevated Serum Marker in Testicular Cancer, A. Neumann, T. Keller, D. Jocham, C. Doehn

      CAUTION: Studies indicate that smoking habits of subjects should be taken into account when evaluating serum hPLAP levels.

    • Conditions of sale

      To read the end user conditions of sale for this product please visit our Resource center.

    • Citations

    • Product inquiry

      CAPTCHA

      The provision of your data implies your consent to the processing of your data in our database and, depending on the option you choose, to receiving our monthly newsletter by e-mail.

      For more information on how we process your personal data and regarding the rights you have in this respect, we refer to our privacy policy, which we hold at your disposal HERE.

      If you no longer wish to receive our newsletter, you have the option to unsubscribe via the ‘unsubscribe’ tool at the bottom of the newsletter. If you want to have your data removed from our database, please contact us at: privacy@fujirebio.com.

    Veuillez confirmer que vous êtes un professionnel de la santé

    Le contenu de ce site web est en partie réservé aux professionnels de santé qui sont directement impliqués dans la fourniture de services de soins de santé aux patients. Si vous êtes un professionnel de santé et que vous disposez de tous les droits d'accès, veuillez confirmer en cliquant sur le bouton 'oui'.

    Choose your country or region

    Once you have made this selection we will show you only the content that is relevant for your country. You can change this setting any time by clicking on the flag in the top toolbar of our website and choosing another country.
    The content of this website is in part restricted to healthcare professionals who are directly involved in the provision of healthcare services to patients. If you are a health professional and you have full access rights, please check this box and confirm below.